This is a past event. Registration is closed. View other The Society of Gynecologic Oncology of Canada events.
Jada Hamilton
Associate Attending Psychologist at Memorial Sloan Kettering Cancer CenterDr. Jada Hamilton is an Associate Member at Memorial Sloan Kettering Cancer Center, as well as an Associate Attending Psychologist in the Behavioral Sciences Service, Department of Psychiatry and Behavioral Sciences and in the Clinical Genetics Service, Department of Medicine at Memorial Hospital in New York, New York. Prior to joining the faculty of Memorial Sloan Kettering, Dr. Hamilton received a BA in Genetics and Psychology from Ohio Wesleyan University (2004), an MA and PhD in Social and Health Psychology from Stony Brook University (2006, 2009), and an MPH from the Mailman School of Public Health at Columbia University (2010). Dr. Hamilton also completed a postdoctoral fellowship as part of the National Cancer Institute’s Cancer Prevention Fellowship Program. Dr. Hamilton’s program of research addresses the intersection of behavioral science, cancer prevention, and genomics, with the goal of translating advances in genetic and genomic medicine into improved cancer care that is of high quality, aligned with patient preferences, and ultimately improves public health. She is currently leading a five-year study to assess how cancer patients and their families respond to inherited risk information that is revealed as part of tumor sequencing, and a study to examine the effects of novel breast cancer genetic risk feedback on patients’ decision-making, psychological, and behavioral outcomes. Outside of the lab, Dr. Hamilton enjoys baking and cooking, reading, competing with her pub trivia team, and exploring restaurants throughout New York City.
Mark Robson
Medical oncologist, Chief, Breast Medicine Service at Memorial Sloan Kettering Cancer CenterI am a board-certified medical oncologist who specializes in the identification and management of individuals who have inherited an increased risk for cancer. I concentrate on helping men and women with cancer incorporate genetic information into their treatment plan. For those who are at increased risk, but have not been diagnosed, I work to develop a plan that will help them either prevent the development of cancer, or limit its impact if it occurs. Along the same lines, my research focus has studied the best ways to use genetic information to improve the outcomes of those with or at risk for hereditary cancers of all types. Consistent with the goals I pursue in my clinical genetics work, my oncology practice is weighted toward the management of young women with breast cancer, especially hereditary breast cancer. As part of that practice, I participate in the development of new treatments, such as PARP inhibitors, which may be particularly useful for this group of women. Finally, I also maintain a separate practice where I coordinate screening for women with mutations in BRCA1 or BRCA2.
Miranda Steenbeek MD, PhD
Radboud University Medical CentreFifth-year resident in obstetrics and gynecology, currently focusing on gynecologic oncology. In April 2022 I successfully defended my thesis ‘Prevention and etiology of serous cancer of the female genital tract’.
Ranjit Manchanda
Professor of Gynaecological Oncology & Consultant Gynaecological Oncologist at Wolfson Institute of Population Health, Queen Mary University of London and Barts Health NHS Trust, London, UKRanjit Manchanda is a Professor at Wolfson Institute of Population Health, Queen Mary University of London; Consultant Gynaecological Oncologist at Barts Health NHS Trust, London, UK; Honorary Professor Department of Health Services Research, London School of Hygiene & Tropical Medicine and holds the Distinguished Infosys Chair in Oncology at All India Institute of Medical Sciences, Delhi, India.
Ranjit’s research interests are focused around Targeted Precision Prevention. This includes population-based genetic testing, mainstreaming genetic testing and precision medicine approaches for risk prediction, stratification, targeted screening, targeted cancer prevention, along with health economic issues related to these areas of research. He is the Principal Investigator on the PROTECTOR, PROTECT-C, DETECT-2, GCaPPS, PROMISE Pilot trials, and SIGNPOST, JHCR, UKCOGS, PRESCORES, RRESDO studies.
Ranjit received the Ovacure Innovation Challenge Award (Copenhagen) in Sep 2022, an NHS Innovation Accelerator (NIA) Fellowship for Population Genetic Testing in 2019, RCOG Blair Bell award (2018) for research in population testing, and the Dr Shyam Agarwal Memorial Oration award (2019) for contribution to cancer genetics. He has also received the Helen Harris Memorial Trust travelling Fellowship and NIHR Clinical Lecturer Fellowship awards.
He co-Leads the Cancer Prevention Theme at the Barts CRUK Cancer Centre and co-Leads the Cancer Prevention Unit at Wolfson Institute of Population Health. He is the Specialty Research Lead for Gynaecological Cancer, NIHR North Thames Clinical Research Network (CRN). He leads the high-risk women’s Precision Prevention Clinic at Barts Health and is chair of the London Cancer High risk Gynaecological Cancer MDT. He is the Topic Advisor (Clinical Lead) for the NICE guideline on Ovarian cancer: identifying and managing familial and genetic risk. He is a member of the NCRI Ovarian Cancer Surgical Sub group and has a keen interest in ultra-radical debulking surgery for ovarian cancer. He is a member of a number of other advisory bodies and oversight committees.
He is the Integrated Academic Training Programme Director, London Specialty School of Obstetrics & Gynaecology, Health Education England, & Lead for the RCOG Advanced Professional Module (APM) in Clinical Research for London. He is a member of number of committees related to research and training. He has led a number of training initiatives in Gynaecological Oncology across Europe.
He has published and lectured widely on areas related to his research interest.
He has served as President of the European Network of Young Gynaecological Oncologists (ENYGO) and member of the European Society of Gynaecological Oncology (ESGO) Council from 2011-2013.
Alon Altman
Professor, Gynecologic Oncologist at Dr. Alon Altman Medical Corporation
Angelina Tryon, MS, CGC
Genetic counsellor at Peter Gilgan Center for Women’s Cancers at the Women’s College Hospital & Research InstituteAngelina Tryon is a certified genetic counsellor working at the Genetics/Hereditary Breast Cancer Clinic at Women’s College Hospital. She is also the study coordinator and genetic counsellor for The Screen Project, a Canadian national initiative to make hereditary cancer testing available to Canadians at an accessible price. She received her MS in Human Genetics from Sarah Lawrence College in 2018 and has been working in the hereditary cancer genetics space ever since.
Laurence Bernard
Fellow, Gynecologic Oncology at MD Anderson Cancer Centre
Steven Bisch
Gynecologic Oncologist at Tom Baker Cancer Centre
Genevieve Bouchard-Fortier
Gynecologic Oncologist at University Health Network
Jennifer Brown-Broderick MD, MSc, FRCSC, DABOG
Gynecologic Oncologist, Assistant Professor Division of Oncology & Department of Gynecology at Saskatchewan CancerA practicing engineer, Dr. Brown Broderick later shifted to medicine, graduating from the University of Alberta in 2009. Having completed her residency and fellowship in gynecologic oncology at the University of Ottawa, she practiced for 4 years in Rochester, NY before returning to Canada. A gynecologic oncologist in Saskatoon and assistant professor of oncology at the University of Saskatchewan, she currently directs several clinical trials as primary investigator, including Saskatchewan’s first in gynecologic oncology.
Mark Carey
Professor, Gynecologic Oncology at Vancouver General HospitalHe completed his medical degree and Obstetrics & Gynaecology residency at the University of Western Ontario, a fellowship in Gynaecologic Oncology at the University of Toronto and McMaster University, and a research fellowship in the Department of Systems Biology at the University of Texas, MD Anderson Cancer Centre. He runs his research program through OvCaRe and has funding through private donations and his medical corporation to support his laboratory staff. He is Co-Investigator on a recent grant award from the Cancer Research Society with Dr. Cheng-Han Lee, and has done contract research for investigational drug testing. His laboratory has been supported as well by research funds from Dr. Dianne Miller and the Division of Gyn Oncology, the BC Cancer Agency, the Carraresi Foundation OvCaRe Research Grant, and VGH and UBC Hospital Foundations. Mark regularly supervises PhD and MSc candidates and is a member of the department’s Research Advisory Committee.
Prafull Ghatage
Gynecologic Oncologist at Tom Baker Cancer Centre
Janice Kwon
Gynecologic Oncologist, Professor and Vice Head, Department of Obstetrics and Gynecology at The University of British ColumbiaDr. Kwon is a Gynecologic Oncologist, Professor and Vice Head of the Department of Obstetrics and Gynecology at UBC. She serves as Chair of the Priority and Evaluations Committee at BC Cancer, the Research & Outcomes Evaluation Committee for the BC Cancer Surgery Network, and the National BRCA Collaborative. Her expertise is in hereditary cancer syndromes and conducting cost-effectiveness analyses of testing criteria and risk-reducing interventions. Her background includes a Masters degree in Public Health from Harvard and post-doctorate at the University of Texas M.D. Anderson Cancer Center in Houston. She currently holds a Health Professional Investigator Award from the Michael Smith Foundation for Health Research.
Helen MacKay
Head, Medical Oncology & Hematology at Sunnybrook Health Sciences CentreDr. Helen MacKay is a Medical Oncologist and Professor of Medicine at the University of Toronto. She is Head of the Division of Medical Oncology and Hematology at the Odette Cancer Centre at Sunnybrook Health Sciences Centre, and Senior Scientist at the Sunnybrook Research Institute. Dr. MacKay's clinical practice and research focus is on gynecological cancers. Her research involves collaborating with translational and basic scientists in the development and validation of novel therapeutic strategies. She is the current President of the Society of Gynecologic Oncologists of Canada (GOC). She co-chairs the NCI (US), Ovarian Cancer Task Force. She also chairs the Ovarian Group and sits on the executive of the Gyne committee of the Canadian Cancer Trials Group (CCTG), and represents CCTG at the Gynecologic Cancer Intergroup. She is a past chair of both the Gynecologic Cancer Education and Scientific Committees for ASCO. With specific reference to uterine cancers, she is a member of the TRANSPORTEC group, and sits on the Corpus Committee of NRG, and was the co-chair of the NCI Endometrial Cancer Clinical Trials Planning Committee.
KM
Katie Macpherson
Senior Marketing Manager at AstraZeneca Canada Inc
Jeanna McCuaig, MSc, PhD, CGC, CCGC
Genetic counsellor at Bhalwani Familial Cancer Clinic, Princess Margaret Cancer CentreJeanna McCuaig is a certified genetic counsellor working at the Bhalwani Familial Cancer Clinic at the Princess Margaret Cancer Centre. She received her MSc in Genetic Counselling from the University of Toronto in 2010 and her PhD from Lawrence S. Bloomberg Faculty of Nursing at the University of Toronto in 2022. Jeanna's clinical research focusses on the implementation and evaluation of novel genetic counselling and testing strategies for hereditary cancer risk. Jeanna is also an active member of the Canadian Association of Genetic Counsellors and recently led a working group to develop national resources to support implementation of oncologist-ordered genetic testing.
Jacob McGee
Gynecologic Oncologist, Secretary-Treasurer at London Health Science Centre, The Society of Gynecologic Oncology of Canada (GOC)Jacob McGee is a gynecologic oncologist and an associate professor in the Schulich School of Medicine at Western University. He is the regional gynecologic oncology champion for southwestern Ontario, a Director for the Gynecologic Oncology Group of Ontario (GOGO), and the incoming Secretary-Treasurer for The Society of Gynecologic Oncology of Canada. His research interests include optimizing testing for hereditary cancer syndromes and outcomes research using ICES (institute for clinical evaluative sciences) datasets.
Gregg Nelson
Professor, Gynecologic Oncology at Tom Baker Cancer Centre
Julie My Van Nguyen
Gynecologic Oncologist at Juravinski Hospital/Hamilton Health Sciences
Sophia Pin
Gynecologic Oncologist at Alberta Health Services
Annick Pina
Gynecologic Oncologist at Le Centre Hospitalier de l'Universite de Montreal
Marie Plante
Gynecologic Oncologist at Centre Hospitalier Universitaire de Quebec - L'Hotel dieu de QuebecDr. Plante obtained her medical degree from Laval University in 1985 and completed her residency in obstetrics and gynecology at McGill University in 1990. She continued with a 3-year subspecialty in gynecologic oncology at the Memorial Sloan-Kettering Cancer Center in New York in 1993. Since then, she has worked as a gynecologist-oncologist at l’Hôtel-Dieu de Québec.
Dr. Plante is a Professor in the Department of Obstetrics and Gynecology at Laval University. She is head of the oncology-gynecology department and in charge of clinical research at l’Hôtel-Dieu de Québec.
JR
Julie Reynolds
Oncology Diagnostics, AstraZeneca at AstraZeneca Canada
Alison Ross
Director, Knowledge Mobilization of Ovarian Cancer CanadaAlison is Director, Knowledge Mobilization at Ovarian Cancer Canada. She works closely with colleagues, clinicians, research scientists, patients, and caregivers from across Canada to ensure that information and resources shared with the ovarian cancer community are of the highest quality and informed by the most up to date scientific evidence. She also plays a key role in the planning, development, implementation and evaluation of patient education and outreach strategies, and provides direct support to those diagnosed with ovarian cancer.
Alison has 12 years of professional experience in higher education. She is a Professor and Academic Coordinator in the Centre for Health Sciences at George Brown College and holds a PhD in Health Studies from McMaster University. Her research work centralizes insights from diverse patient communities to inform the development of medical programming and to advance patient-focused strategies. She earned a Bachelor of Arts (Honours) in Health Studies and Psychology from Queen’s University, and a Masters of Arts (Honours) in Health Studies from McMaster University. Alison’s first experience in the cancer care community was as a Research Associate in the clinical Cancer Survivorship Program at the University Health Network.
Shannon Salvador
Assistant Professor, Division of Gynecology Oncology, Segal Cancer Centre at McGill University - Jewish General HospitalTrained in advanced laparoscopic surgery in Vancouver, Dr Salvador is currently working at the Jewish General Hospital in Montreal where she is including robotic surgical techniques in the treatment of gynaecological cancers. Her current research focuses on the molecular analysis of endometrial cancers.
Alicia Tone
Scientific Advisor at Ovarian Cancer CanadaDr. Alicia Tone joined the Ovarian Cancer Canada team as Scientific Advisor in May 2019, and became OvCAN Project Manager the following November. Her deep well of experience in the ovarian cancer field includes a Ph. D. in ovarian cancer biology from the University of Toronto, postdoctoral studies in ovarian cancer genomics at B.C. Cancer Agency, and more than seven years as Scientific Associate in the Division of Gynecologic Oncology at the Princess Margaret Cancer Centre.
Danielle Vicus
Gynecologic Oncologist at Sunnybrook Health Sciences Centre - Odette Cancer CentreDr. Danielle Vicus is a gynecologic oncologist at the Odette Cancer Center, Sunnybrook Health Sciences Center. She completed her fellowship in Gynecologic Oncology at the University of Toronto and obtained a Master’s of Science in Clinical Epidemiology through the Institute of Health Policy, Management and Evaluation at the University of Toronto. She is currently an Associate Professor at the University of Toronto and an Affiliate Scientist at the Sunnybrook Research Institute.
Dr. Vicus She is the GOC chair for the communities of practice and is a member of the GOC executive. She is also the QI (Quality Improvement) lead for the division of Gynecologic Oncology at Sunnybrook Health Sciences and is a voting member on the NRG Oncology Rare Tumour Cmt. Her key research interests are rare gynecologic tumours and cancer screening strategies in women. She has received multiple grants and awards during her career.
Karla Willows
Gynecologic Oncologist at Queen Elizabeth 2- Victoria General Site
Tiffany Zigras
Gynecologic Oncologist at Trillium Health PartnersDr. Zigras is a Gynecologic Oncologist at Credit Valley Hospital, Trillium Health Partners in Mississauga, Ontario. She is an Assistant Professor at the University of Toronto. She completed her residency at Bridgeport Hospital, Yale University in Obstetrics and Gynecology. She then completed a fellowship at the University of Toronto in Gynecologic Oncology. During her fellowship program she completed a Master of Science in clinical epidemiology through the Institute of Health Policy, Management and Evaluation. Her interest lies in pre-invasive and invasive lesions of the vulva, cervix and ovary and genetics. She also has a strong interest in Medical Education and Surgical Education.